Related Experiment Videos
MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma
Patrick Ying-Kit Yue1, Wai-Yan Ha1, Chi-Chiu Lau1
1Department of Biology, Faculty of Science, Hong Kong Baptist University, Hong Kong, China.
Abstract:
MicroRNAs (miRNAs) are small non-coding RNAs that play a crucial role in pathogenesis of human cancers. Several miRNAs have been shown to involve in nasopharyngeal carcinoma (NPC) pathogenesis through alteration of gene networks. A global view of the miRNA expression profile of clinical specimens would be the best way to screen out the possible miRNA candidates that may be involved in disease pathogenesis. In this study, we investigated the expression profiles of miRNA in formalin-fixed paraffin-embedded tissues from patients with undifferentiated NPC versus non-NPC controls using a miRNA real-time PCR platform, which covered a total of 95 cancer-related miRNAs. Hierarchical cluster analysis revealed that NPC and non-NPC controls were clearly segregated. Promisingly, 10 miRNA candidates were differentially expressed. Among them, 9 miRNAs were significantly up-regulated of which miR-205 and miR-196a showed the most up-regulated in NPC with the highest incidence percentage of 94.1% and 88.2%, respectively, while the unique down-regulated miR-150 was further validated in patient sera. Finally, the in vitro gain-of-function and loss-of-function assays revealed that miR-150 can modulate the epithelial-mesenchymal-transition property in NPC/HK-1 cells and led to the cell motility and invasion. miR-150 may be a potential biomarker for NPC and plays a critical role in NPC tumourigenesis.
Insights
MicroRNAs (miRNAs) are key in nasopharyngeal carcinoma (NPC) development. This study identified 10 differentially expressed miRNAs in NPC tissues, with miR-150 showing potential as a biomarker and playing a role in tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs implicated in human cancer pathogenesis.
- Specific miRNAs are known to influence nasopharyngeal carcinoma (NPC) through gene network alterations.
- Understanding miRNA expression profiles in clinical samples is crucial for identifying disease-related candidates.
Purpose of the Study:
- To investigate miRNA expression profiles in undifferentiated nasopharyngeal carcinoma (NPC) versus non-NPC controls.
- To identify potential miRNA biomarkers involved in NPC pathogenesis.
- To elucidate the functional role of specific miRNAs in NPC cell behavior.
Main Methods:
- Utilized a miRNA real-time PCR platform to analyze expression of 95 cancer-related miRNAs in formalin-fixed paraffin-embedded tissues.
- Employed hierarchical cluster analysis for segregation of NPC and non-NPC samples.
- Performed in vitro gain-of-function and loss-of-function assays on NPC/HK-1 cells.
Main Results:
- Hierarchical clustering clearly distinguished NPC from non-NPC controls.
- Identified 10 differentially expressed miRNA candidates, with 9 significantly upregulated and 1 downregulated.
- miR-205 and miR-196a were highly upregulated; miR-150 was uniquely downregulated and validated in patient sera.
- miR-150 modulated epithelial-mesenchymal-transition, cell motility, and invasion in NPC/HK-1 cells.
Conclusions:
- The study identified a distinct miRNA expression profile in undifferentiated NPC.
- miR-150 demonstrates potential as a biomarker for NPC and plays a critical role in NPC tumorigenesis.
- Further investigation into the identified miRNAs could lead to novel diagnostic and therapeutic strategies for NPC.